C-MER Medical Holdings Limited (stock code: 03309) reported a repurchase of 200,000 shares on 25 November 2025, executed on the Hong Kong Stock Exchange at a highest price of HKD 1.73 and a lowest price of HKD 1.71 per share, resulting in an approximate average of HKD 1.7204. Following this transaction, the company holds 1,238,272,870 issued shares (excluding treasury shares) and 17,288,000 treasury shares, maintaining a total of 1,255,560,870 shares.

The repurchase aligns with a shareholders’ resolution approved on 19 May 2025, which authorized the buyback of up to 125,556,087 shares. The transaction represents 0.0161% of the number of issued shares (excluding treasury shares) at the time that mandate was granted. According to the report, several share transactions from July 2024 to May 2025 are pending cancellation. The company will observe a moratorium period until 25 December 2025 before issuing new shares or transferring any treasury shares.